O presente estudo objetivou a avaliação do potencial regenerativo e trófico das CS e do fator neurotrófico PEDF sobre os neurônios da medula espinal através da cultura destas células in vitro assim como no modelo experimental da lesão medular contusa in vivo. CS foram cultivadas a partir de fragmentos de nervo ciático de ratos adultos jovens. As culturas primárias foram purificadas e utilizadas em experimentos in vitro e in vivo. Para avaliar se a cultura de CS tratadas com o PEDF proporciona o trofismo dos neurônios da medula espinal, estes foram cultivados a partir de fragmentos da medula espinal de ratos Wistar neonatos e tratados com o meio condicionado das CS (MCCS) pré-tratadas ou não com formas específicas do PEDF. A resposta trófica foi estudada através da quantificação do número de células bem como da área dos prolongamentos e dos corpos celulares dos neurônios cultivados sobreviventes no decurso temporal da cultura, utilizando-se método estereológico específico. Em outra série de experimentos, Ratos Wistar adultos foram submetidos à lesão medular contusa no 10º-11° segmento torácico pelo sistema NYU Impactor e tratados com inoculações locais de CS e do seu meio condicionado na presença ou não do PEDF. Ao término do procedimento cirúrgico, os ratos foram submetidos aos testes do comportamento BBB, CBS durante 6 semanas. Os tratamentos aplicados à cultura de neurônios da medula espinal demonstraram que o MCCS, pré-tratado ou não com diferentes formas moleculares do PEDF e os fatores por si só possuem ações tróficas e plásticas em relação aos neurônios da medula espinal. Foi observado que o MCCS exerceu um efeito de arborização e de trofismo sobre o corpo neuronal dos neurônios medulares, sendo que este efeito foi potencializado quando o MCCS foi obtido a partir de CS pré-tratadas com os fatores nPEDF ou coPEDF, e de intensidade ainda maior quando as formas puras dos fatores em questão foram adicionadas à cultura. Os animais submetidos ao trauma contuso da medula espinal que foram tratados com a inoculação das CS, pré-tratadas ou não com o nPEDF, do meio condicionado destas células e dos fatores nPEDF e coPEDF apresentaram melhor recuperação funcional em relação ao grupo controle. A partir dos dados obtidos neste trabalho pode-se dizer que as CS, seu meio condicionado e o PEDF possuem ações importantes sobre os neurônios da medula espinal, possibilitando a modulação do processo de recuperação funcional deste órgão após o trauma. / The present study aimed the assessment of the trophic and regenerative potential of the Schwann cells (SC) and of the neurotrophic factor PEDF on the spinal cord neurons by means of cultures of those cells in vitro as well as in an experimental model of a contused spinal cord lesion in vivo. SC were cultivated from sciatic nerves fragments of young adult rats. The primary cultures were purified and used in in vitro and in vivo experiments. To evaluate if the SC cultures treated with PEDF provide the trophism of the spinal cord neurons, these were cultivated from spinal cords fragments of new born rats and treated with SC conditional medium (SCCM), of cells pre-treated or not with specifics isoforms of PEDF. The trophic responses were analyzed by the quantification of the cell number, and the area of sprounting and perycaria of the survived neuronal cells in the culture time course using a specific stereological method. In another series of experiment, adults Wistar rats were submitted to a contuse spinal cord lesion in the 10º-11º thoracic level by means of the NYU Impactor and treated with local injection of SC and your CM with the presence or not of the PEDF. In the end of the surgical procedure, the rats were submitted to behaviors testes as the BBB and the CBS during the 6 follow weeks .The spinal cord neuron treatments show that the SCCM, prétreated or not with specifics molecular isoforms of PEDF and this factors by themselves demonstrated trophic and plastic actions with the spinal cord neurons. It was observed that the SCCM exerted a sprouting and trophic effect on the neuronal body of the spinal cord neurons, and that this effect was enhanced when the SCCM was achieved from SC pre-treated with PEDF, and even better when the pures forms of the PEDF was added to the culture. The animals that received the spinal cord lesion and were treated with injection of SC, pre-treated or not with nPEDF, or with the conditioned medium of those cells and the factors nPEDF or coPEDF showed a better functional recovery when compared to the control groups. The results of this study showed that the SC, your conditioned medium and the PEDF play an important role in the spinal cord neurons, allowing the modulation of the functional recovery process of this organ after the trauma.

A utilização experimental de CS é apontada como uma perspectiva benéfica no tratamento da lesão medular devido estas células produzirem fatores neurotróficos e citocinas inflamatórias que influenciam o ambiente do sistema nervoso. Ratos machos foram submetidos à lesão medular contusa de intensidade moderada (25mm) ao nível do 11o segmento torácico. As CS cultivadas a partir do nervo ciático foram pré-tratadas ou não com as citocinas inflamatórias TGF-1 (5ng/ml) ou TNF- (30ng/ml) e inoculadas no local da lesão imediatamente após o trauma. O grupo controle e o grupo lesão receberam inoculação do meio de cultura. Após a cirurgia os ratos foram submetidos à análise do comportamento motor durante 8 semanas. O BBB mostrou melhora do comportamento motor ao longo do período analisado para o grupo tratado com as CS. Este efeito não foi potenciado pelo pré-tratamento das CS com as citocinas inflamatórias. As medulas espinais foram processadas e receberam coloração pelo Violeta de Cresilo ou imunomarcação com a GAP-43, o glutamato, o NPY, a substância P, a GFAP, o FGF-2 e do NG2. Os tratamentos realizados neste desenho experimental não alteraram as respostas neuroprotetivas. Segundo análise estereológica não foram encontradas diferenças no número estimado de neurônios remanescentes e no volume de tecido preservado entre os grupos que receberam lesão medular. A lesão promoveu uma diminuição da imunorreatividade da GAP-43 no corno anterior, que foi revertida quando a lesão recebeu tratamento com as CS prétratadas ou não com a citocina TGF-1. O resultado do tratamento com as CS foi o de aumento na imunorreatividade do glutamato nas células no corno anterior e no funículo lateral quando comparado com o grupo lesão. Para o NPY no corno anterior houve aumento da imunorreatividade do grupo tratado com as CS apenas em comparação ao grupo controle. Já no funículo lateral a lesão aumentou a imunorreatividade NPY em comparação ao grupo controle, inclusive quando houve tratamento com as CS, mas este deixou de existir quando houve prétratamento das CS com as citocinas. Referente ao FGF-2, no funículo lateral e no fascículo grácil houve aumento da imunorreatividade no grupo tratado com as CS, acrescidas ou não de TGF-1, apenas em comparação ao grupo controle. Porém, o tratamento com as CS aumentou a imunorreatividade do FGF-2 na região do fascículo grácil. A imunorreatividade do FGF-2 aumentou na região de epicentro da lesão, e este efeito foi mantido nos grupos tratados com as CS, acrescidas ou não de TGF-1. Houve significante aumento da imunorreatividade da GFAP no corno anterior e no funículo lateral quando os grupos lesados foram tratados com as CS e/ou citocinas comparado ao grupo controle. Na região do epicentro, a lesão promoveu aumento da imunorreatividade da GFAP, que foi potencializado quando houve tratamento com as CS. A lesão promoveu aumento da imunorreatividade do NG2 no epicentro, inclusive quando houve tratamento com as CS. O melhor desempenho motor observado no grupo que recebeu inoculação de CS provavelmente está relacionado a fatores como respostas plásticas e neuroquímicas no tecido preservado da medula espinal. / The experimental use of Schwann cells is indicated on spinal cord treatment due to the ability of these cells to produce neurotrophic factors and inflammatory cytokines, influencing nervous system environment. Male rats were submitted to a moderate spinal cord contusion (25mm) at 11th thoracic level. Culture Schwann cells were obtained from sciatic nerves and pre-treated or not with inflammatory cytokines TGF-1 (5ng/ml) or TNF- (30ng/ml) and then were inoculated in lesion site just after trauma. Sham and lesion groups received culture medium inoculation. After surgery, rats were submitted to behavior analyses during 8 weeks. BBB showed motor recovery in the Schwann cell group. This effect was not potentiated by pretreated of Schwann cells with inflammatory cytokines. The spinal cords were processed for Cresil Violet or immunolabeling to GAP-43, glutamate, NPY, substance P, GFAP, FGF-2 and NG2. Stereological analyses showed no differences in the estimated number of remaining neurons and in the volume of the preserved tissue among the lesioned groups. The injury reduced GAP-43 immunoreactivity in ventral horn, which was reverted when injury was treated with Schwann cells pre-treated or not with TGF-1. Schwann cell treatment enhanced glutamate immunoreactivity in the ventral horn and lateral funiculus compared with lesioned group. In ventral horn, NPY immunoreactivity was enhanced in Schwann cells group compared with sham group. In lateral funiculus, the injury or the treatment with Schwann cells increased NPY immunoreactivity, comparing with sham group. FGF-2 of lateral funiculus and gracile fasciculus enhanced in Schwann cells group. Treatment with Schwann cells enhanced FGF-2 immunoreactivity in gracile fasciculus. Injury enhanced FGF-2 immunoreactivity in epicenter region, also observed in the groups treated by Schwann cells. In ventral horn and lateral funiculus when the lesioned groups were treated by Schwann cells and/or cytokines there was significant increase in GFAP immunoreactivity compared with sham group. In epicenter, the injury promoted GFAP immunoreactivity increase that was potentiated by Schwann cells treatment. The injury produced NG2 increase in epicenter, included by Schwann cells treatment. The motor recovery showed in Schwann cell group is probably related to neurochemical plasticity in spinal cord preserved tissue.

Les cellules de Schwann sont responsables de la myélinisation du système nerveuxpériphérique. C’est un phénomène complexe et finement régulé. En effet, des altérationsde l’expression touchant les protéines de la myéline périphérique (P0 et PMP22)peuvent provoquer des pathologies comme la Charcot‐Marie‐Tooth. Par ailleurs, lescellules de Schwann subissent d’importantes modifications de leur cytosquelette aucours du processus de myélinisation.Nous avons identifié la voie Wnt/β‐caténine comme directement impliquées dansla régulation de l’expression des gènes de la myéline P0 et PMP22 à la fois in vitro maiségalement in vivo. De plus, nous avons initié la démonstration de l’implication de la voieWnt non canonique au cours de ce même processus. Par ailleurs, nous avons montré queles ligands Wnts aussi bien canoniques que non canoniques pouvaient provoquerl’allongement des extensions des cellules de Schwann. Le chlorure de lithium est uninhibiteur de la GSK3β, mimant l’activation de la voie Wnt/β‐caténine. Il provoque unimportant allongement des cellules de Schwann accompagné de profonds remaniementsde l’architecture interne. Par la suite nous nous sommes intéressés aux effets d’unelésion sur la remyélinisation. La voie Wnt/β‐caténine est réactivée par une lésion in vitrotandis que le lithium accélère la récupération fonctionnelle du battement des vibrissesde souris après pincement du nerf facial, améliore les structures de la gaine de myélineet induit l’expression des gènes de la myéline in vivo.ConclusionNotre travail a mis en évidence le rôle majeur des voies Wnt canoniques et noncanoniques dans la régulation de l’expression de gènes de la myéline et dans lecytosquelette des cellules de Schwann. / The myelination is performed by Schwann cells in the peripheral nervous system.Myelination involves the extension of large sheaths of membranes and their wrapping around axons, accompanied by the coordinated synthesis of a variety of myelin components, including myelin‐specific proteins (MPZ and PMP22).We identified the Wnt/β‐caténin pathway as an essential and direct driver of myelin gene expression and myelinogenesis. Moreover, we identified non canonical Wnt protein as regulators of myelin genes expression MPZ and PMP22. Canonical and non canonical Wnt protein elongate the Schwann cells in vitro by microtubules stabilizationmechanisms.We used lithium chloride, an inhibitor of GSK3β to test either effects on Schwann cells cytoskeleton and recovery after nerve crash in vivo. Lithium chloride provokes Schwann cells elongation and biochemicals modifications by enhencing cholesterol as we show by IR spectroscopy. Lithium chloride accelerates the recovery of the whisker mouvements after nerve crash, provokes the remyelination of sciatic neve after crush and stimulates myelin genes expression.ConclusionWe have identified Wnt pathways as direct driver of myelin genes expression and important for cytoskeleton stabolization. Our findings, open new perspectivesin the treatment of nerves demyelination by administration of GSK3βinhibitors like lithium.

This body of work details the exploitation of an incredibly powerful neural culture system, which enables the in vitrostudy of events involved in peripheral nervous system (PNS) development. Using a myelinating dorsal root ganglion (DRG) explant culture system, node of Ranvier formation and maintenance and the associated generation and maturation of myelin segments was examined. In addition, Schwann cell (SC) development, dynamics, and migration were extensively studied. First, in characterizing these cultures, the discrete axonal localization of specific ankyrin isoforms was revealed. Ankyrins are peripheral membrane proteins that immobilize classes of integral membrane proteins to the spectrin based-membrane skeleton. Ankyrins interact with proteins such as the voltage-dependent/gated sodium channel (vgsc) and members of the L1 family of cell adhesion molecules. These interactions are physiologically relevant to the formation of membrane specializations involved in axon guidance and the initiation and propagation of action potentials. We examined ankyrinB and ankyrinG expression in cultured DRG explants, which allowed visualization of individual axons. AnkyrinB and ankyrinG exhibited differential localizations to specific axonal populations. This was evident as early as one day in vitro and persisted over time. In mature pre-myelinated cultures, axons having an apparent diameter of less than 1 µm predominantly expressed ankyrinB, whereas axons having a diameter greater than or equal to 1 µm predominantly expressed ankyrinG (based on immunocytochemical reactivity). When myelination was induced, ankyrinGwas appropriately localized to sites of nodal development flanked by myelinating glial processes in the large caliber axons. These observations suggest that axons destined for myelination may express a distinct complement of peripheral, and perhaps integral, membrane proteins as compared to those observed in non-myelinated axons. These distinguishing features may play a role in the selection of axons for myelination. This work was followed with defining the role axo-glial interactions play in organizing domains along the axon being myelinated. Nodes of Ranvier are specialized, highly polarized axonal domains crucial to the propagation of saltatory action potentials. In the PNS, axon-glial cell contacts have been implicated in SC differentiation and the formation of nodes of Ranvier. SC microvilli establish axonal contact at mature nodes, and their components have been observed to localize early to sites of developing nodes. However, a role for these contacts in node formation remains controversial. Using the myelinating explant culture system, we observed that SCs reorganize and polarize microvillar components, such as the ezrin-binding phosphoprotein 50kDa (EBP50)/regulatory co-factor of the sodium-hydrogen exchanger isoform 3 (NHERF-1), actin, and the activated ezrin, radixin, and moesin (ERM) family of proteins, concomitant with myelination in response to inductive signals. These components were targeted to the SC distal tips where live cell imaging revealed novel, dynamic growth cone-like behavior. Further, localized activation of the Rho signaling pathway at SC tips gave rise to these microvillar component-enriched “caps” and influenced the efficiency of node formation. Extending these findings, a more profound examination of SC dynamics was undertaken. This was a particularly important experimental transition, as SC motility is crucial in the development and regeneration of the PNS. The seemingly equivalent bipolarity of mature SCs represents a conundrum in terms of directed motility. Fluorescence time-lapse microscopy of transfected SCs within the myelinating DRG explants revealed a novel cycling of these cells between static, bipolar and motile, unipolar morphologies via asymmetric process retraction and extension. Concentrations of PIP2 (phosphatidylinositol (4,5)-bisphosphate), activated ERMs, and EBP50 delineated the transitory asymmetry associated with the generation and neuron-like migration of the unipolar cell. EBP50 over-expression enhanced unipolar SC migration, suggesting a new role for this adaptor protein in cell motility. Further, the ERMs themselves were found to be essential to both motility and process dynamics with ERM disruption yielding a dysfunctional, multipolar SC phenotype. We propose this novel form of motility may be associated with the correct alignment and spacing of SCs along axons prior to elaboration of the myelin sheath. These compiled studies present significant advances in understanding and examining axo-glial interactions in the PNS. This work establishes the foundation for further, novel exploration of normal PNS development and the regeneration and repair mechanisms involved in PNS injury and disease states.

No description available.

No description available.

O presente estudo objetivou a avaliação do potencial regenerativo e trófico das CS e do fator neurotrófico PEDF sobre os neurônios da medula espinal através da cultura destas células in vitro assim como no modelo experimental da lesão medular contusa in vivo. CS foram cultivadas a partir de fragmentos de nervo ciático de ratos adultos jovens. As culturas primárias foram purificadas e utilizadas em experimentos in vitro e in vivo. Para avaliar se a cultura de CS tratadas com o PEDF proporciona o trofismo dos neurônios da medula espinal, estes foram cultivados a partir de fragmentos da medula espinal de ratos Wistar neonatos e tratados com o meio condicionado das CS (MCCS) pré-tratadas ou não com formas específicas do PEDF. A resposta trófica foi estudada através da quantificação do número de células bem como da área dos prolongamentos e dos corpos celulares dos neurônios cultivados sobreviventes no decurso temporal da cultura, utilizando-se método estereológico específico. Em outra série de experimentos, Ratos Wistar adultos foram submetidos à lesão medular contusa no 10º-11° segmento torácico pelo sistema NYU Impactor e tratados com inoculações locais de CS e do seu meio condicionado na presença ou não do PEDF. Ao término do procedimento cirúrgico, os ratos foram submetidos aos testes do comportamento BBB, CBS durante 6 semanas. Os tratamentos aplicados à cultura de neurônios da medula espinal demonstraram que o MCCS, pré-tratado ou não com diferentes formas moleculares do PEDF e os fatores por si só possuem ações tróficas e plásticas em relação aos neurônios da medula espinal. Foi observado que o MCCS exerceu um efeito de arborização e de trofismo sobre o corpo neuronal dos neurônios medulares, sendo que este efeito foi potencializado quando o MCCS foi obtido a partir de CS pré-tratadas com os fatores nPEDF ou coPEDF, e de intensidade ainda maior quando as formas puras dos fatores em questão foram adicionadas à cultura. Os animais submetidos ao trauma contuso da medula espinal que foram tratados com a inoculação das CS, pré-tratadas ou não com o nPEDF, do meio condicionado destas células e dos fatores nPEDF e coPEDF apresentaram melhor recuperação funcional em relação ao grupo controle. A partir dos dados obtidos neste trabalho pode-se dizer que as CS, seu meio condicionado e o PEDF possuem ações importantes sobre os neurônios da medula espinal, possibilitando a modulação do processo de recuperação funcional deste órgão após o trauma. / The present study aimed the assessment of the trophic and regenerative potential of the Schwann cells (SC) and of the neurotrophic factor PEDF on the spinal cord neurons by means of cultures of those cells in vitro as well as in an experimental model of a contused spinal cord lesion in vivo. SC were cultivated from sciatic nerves fragments of young adult rats. The primary cultures were purified and used in in vitro and in vivo experiments. To evaluate if the SC cultures treated with PEDF provide the trophism of the spinal cord neurons, these were cultivated from spinal cords fragments of new born rats and treated with SC conditional medium (SCCM), of cells pre-treated or not with specifics isoforms of PEDF. The trophic responses were analyzed by the quantification of the cell number, and the area of sprounting and perycaria of the survived neuronal cells in the culture time course using a specific stereological method. In another series of experiment, adults Wistar rats were submitted to a contuse spinal cord lesion in the 10º-11º thoracic level by means of the NYU Impactor and treated with local injection of SC and your CM with the presence or not of the PEDF. In the end of the surgical procedure, the rats were submitted to behaviors testes as the BBB and the CBS during the 6 follow weeks .The spinal cord neuron treatments show that the SCCM, prétreated or not with specifics molecular isoforms of PEDF and this factors by themselves demonstrated trophic and plastic actions with the spinal cord neurons. It was observed that the SCCM exerted a sprouting and trophic effect on the neuronal body of the spinal cord neurons, and that this effect was enhanced when the SCCM was achieved from SC pre-treated with PEDF, and even better when the pures forms of the PEDF was added to the culture. The animals that received the spinal cord lesion and were treated with injection of SC, pre-treated or not with nPEDF, or with the conditioned medium of those cells and the factors nPEDF or coPEDF showed a better functional recovery when compared to the control groups. The results of this study showed that the SC, your conditioned medium and the PEDF play an important role in the spinal cord neurons, allowing the modulation of the functional recovery process of this organ after the trauma.

A utilização experimental de CS é apontada como uma perspectiva benéfica no tratamento da lesão medular devido estas células produzirem fatores neurotróficos e citocinas inflamatórias que influenciam o ambiente do sistema nervoso. Ratos machos foram submetidos à lesão medular contusa de intensidade moderada (25mm) ao nível do 11o segmento torácico. As CS cultivadas a partir do nervo ciático foram pré-tratadas ou não com as citocinas inflamatórias TGF-1 (5ng/ml) ou TNF- (30ng/ml) e inoculadas no local da lesão imediatamente após o trauma. O grupo controle e o grupo lesão receberam inoculação do meio de cultura. Após a cirurgia os ratos foram submetidos à análise do comportamento motor durante 8 semanas. O BBB mostrou melhora do comportamento motor ao longo do período analisado para o grupo tratado com as CS. Este efeito não foi potenciado pelo pré-tratamento das CS com as citocinas inflamatórias. As medulas espinais foram processadas e receberam coloração pelo Violeta de Cresilo ou imunomarcação com a GAP-43, o glutamato, o NPY, a substância P, a GFAP, o FGF-2 e do NG2. Os tratamentos realizados neste desenho experimental não alteraram as respostas neuroprotetivas. Segundo análise estereológica não foram encontradas diferenças no número estimado de neurônios remanescentes e no volume de tecido preservado entre os grupos que receberam lesão medular. A lesão promoveu uma diminuição da imunorreatividade da GAP-43 no corno anterior, que foi revertida quando a lesão recebeu tratamento com as CS prétratadas ou não com a citocina TGF-1. O resultado do tratamento com as CS foi o de aumento na imunorreatividade do glutamato nas células no corno anterior e no funículo lateral quando comparado com o grupo lesão. Para o NPY no corno anterior houve aumento da imunorreatividade do grupo tratado com as CS apenas em comparação ao grupo controle. Já no funículo lateral a lesão aumentou a imunorreatividade NPY em comparação ao grupo controle, inclusive quando houve tratamento com as CS, mas este deixou de existir quando houve prétratamento das CS com as citocinas. Referente ao FGF-2, no funículo lateral e no fascículo grácil houve aumento da imunorreatividade no grupo tratado com as CS, acrescidas ou não de TGF-1, apenas em comparação ao grupo controle. Porém, o tratamento com as CS aumentou a imunorreatividade do FGF-2 na região do fascículo grácil. A imunorreatividade do FGF-2 aumentou na região de epicentro da lesão, e este efeito foi mantido nos grupos tratados com as CS, acrescidas ou não de TGF-1. Houve significante aumento da imunorreatividade da GFAP no corno anterior e no funículo lateral quando os grupos lesados foram tratados com as CS e/ou citocinas comparado ao grupo controle. Na região do epicentro, a lesão promoveu aumento da imunorreatividade da GFAP, que foi potencializado quando houve tratamento com as CS. A lesão promoveu aumento da imunorreatividade do NG2 no epicentro, inclusive quando houve tratamento com as CS. O melhor desempenho motor observado no grupo que recebeu inoculação de CS provavelmente está relacionado a fatores como respostas plásticas e neuroquímicas no tecido preservado da medula espinal. / The experimental use of Schwann cells is indicated on spinal cord treatment due to the ability of these cells to produce neurotrophic factors and inflammatory cytokines, influencing nervous system environment. Male rats were submitted to a moderate spinal cord contusion (25mm) at 11th thoracic level. Culture Schwann cells were obtained from sciatic nerves and pre-treated or not with inflammatory cytokines TGF-1 (5ng/ml) or TNF- (30ng/ml) and then were inoculated in lesion site just after trauma. Sham and lesion groups received culture medium inoculation. After surgery, rats were submitted to behavior analyses during 8 weeks. BBB showed motor recovery in the Schwann cell group. This effect was not potentiated by pretreated of Schwann cells with inflammatory cytokines. The spinal cords were processed for Cresil Violet or immunolabeling to GAP-43, glutamate, NPY, substance P, GFAP, FGF-2 and NG2. Stereological analyses showed no differences in the estimated number of remaining neurons and in the volume of the preserved tissue among the lesioned groups. The injury reduced GAP-43 immunoreactivity in ventral horn, which was reverted when injury was treated with Schwann cells pre-treated or not with TGF-1. Schwann cell treatment enhanced glutamate immunoreactivity in the ventral horn and lateral funiculus compared with lesioned group. In ventral horn, NPY immunoreactivity was enhanced in Schwann cells group compared with sham group. In lateral funiculus, the injury or the treatment with Schwann cells increased NPY immunoreactivity, comparing with sham group. FGF-2 of lateral funiculus and gracile fasciculus enhanced in Schwann cells group. Treatment with Schwann cells enhanced FGF-2 immunoreactivity in gracile fasciculus. Injury enhanced FGF-2 immunoreactivity in epicenter region, also observed in the groups treated by Schwann cells. In ventral horn and lateral funiculus when the lesioned groups were treated by Schwann cells and/or cytokines there was significant increase in GFAP immunoreactivity compared with sham group. In epicenter, the injury promoted GFAP immunoreactivity increase that was potentiated by Schwann cells treatment. The injury produced NG2 increase in epicenter, included by Schwann cells treatment. The motor recovery showed in Schwann cell group is probably related to neurochemical plasticity in spinal cord preserved tissue.

A Esclerose Lateral Amiotrófica (ELA) é uma doença neurodegenerativa progressiva de evolução rápida, caracterizada pela perda seletiva dos neurônios motores (NM) superiores e inferiores. Recentemente, as células gliais centrais (astrócito, microglia e oligodendrócito) mostraram-se tóxicas aos NM, porém os detalhes moleculares não estão completamente elucidados. Em relação às células gliais periféricas, alterações eletrofisiológicas no nervo ciático do modelo animal da ELA na idade pré-sintomática foram reportadas pelo nosso grupo e os achados de denervação precoce tanto no modelo animal quanto em pacientes sugerem a participação das células de Schwann (CS) na morte neuronal retrógrada na ELA, teoria conhecida como dying back. Nesse contexto, as CS mostraram-se capazes de induzir a retração axonal e a denervação das junções neuromusculares, eventos precoces na doença, ocorrendo possivelmente na fase présintomática. O objetivo deste trabalho foi verificar a influência das CS do modelo experimental na fase pré-sintomática e do paciente com evolução recente da forma esporádica da ELA, na sobrevida e no tamanho dos prolongamentos dos NM in vitro e entender a natureza molecular do fenômeno. Culturas de CS altamente purificadas foram obtidas a partir do nervo ciático do camundongo modelo animal e do nervo periférico de pacientes com ELA. Os NM da medula espinal de camundongos neonatos foram co-cultivados com as CS. A neurodegeneração foi avaliada pela presença do marcador Fluoro-Jade C (FJC). Os NM também foram tratados com o meio condicionado das culturas de CS do modelo animal ou dos pacientes com ELA. Os motoneurônios tiveram os seus prolongamentos contados e a morte neuronal foi identificada pela presença do FJC. Diversos fatores neurotróficos foram quantificados no meio condicionado das culturas de CS pela técnica de ELISA. A reação em cadeia da polimerase quantitativa (do inglês, quantitative polymerase chain reaction - qPCR) foi realizada para detectar alterações nas CS e no nervo periférico que pudessem estar relacionadas com disfunção na unidade CS/NM. Os resultados mostraram que os NM cultivados na ausência das CS mostraram-se mais susceptíveis à morte. Os NM cocultivados com as CS ELA mostraram maior número de perfis neurodegenerativos em comparação com os NM co-cultivados com as CS controle. Após o tratamento com o meio condicionado das CS ELA, os NM mostraram redução no tamanho dos prolongamentos e aumento do número de células em neurodegeneração em comparação com o grupo controle. Quantidades reduzidas dos fatores neurotróficos foram encontradas no meio condicionado das culturas de CS ELA. Alterações na expressão gênica das CS e no nervo periférico evidenciaram disfunções na unidade CS/NM que podem estar contribuindo para o processo neurodegenerativo visto na ELA. Conclui-se que a falência nos mecanismos de neuroproteção pelas CS ELA é um importante mecanismo implicado na morte neuronal, com grande potencial terapêutico / Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by the selective loss of upper and lower motor neurons (MN). Recently, central glia (astrocytes, microglias and olygodendrocytes) were toxic to the MN, but the molecular aspects have not fully described. In relation to the peripheral glia, electrophysiological changes in the sciatic nerve of ALS animal model in the presymptomatic stage have been reported by our group and early denervation findings in both animal models and patients suggests the participation of Schwann cells (SC) in the retrograde neuronal death of ALS , theory known as dying back. In this context, the SC proved to be able to induce axonal retraction and denervation of the neuromuscular junctions, early events in the disease, possibly occurring in the pre-symptomatic phase. The aim of this thesis was to investigate the influence of SC of pre-symptomatic experimental model and from patient with recent evolution of ALS sporadic form, in the survival and axonal length of MN in vitro and understand the molecular nature of the phenomenon. Highly purified SC cultures were obtained from the sciatic nerve of the animal model and from ALS patient\'s peripheral nerve. MN from the newborn mouse spinal cord were co-cultured with SC and the neurodegeneration was assessed by the presence of the marker Fluoro-Jade C (FJC). MN were also treated with conditioned medium from cultures of SC of the animal model or ALS patients. MN had their neuronal length measured and neuronal degeneration was identified by the presence of the FJC. Several neurotrophic factors were measured in conditioned medium of mice and ALS patient\'s SC cultures by ELISA. The chain reaction quantitative polymerase (qPCR) was performed to detect changes in the SC and peripheral nerve that could be related with dysfunction in the functional unit SC/MN. The MN co-cultured with ALS SC showed a greater number of neurodegenerative profiles compared with MN cocultured with control SC. After treatment with ALS SC conditioned medium, MN showed a reduction in the neuronal length and increased number of cells in neurodegeneration compared with the control group. Lower levels of neurotrophic factors were found in the conditioned medium of ALS SC cultures. Changes in the gene expression of SC and peripheral nerve showed dysfunctions in SC/MN unit, which may be contributing to the neurodegenerative process seen in ALS. In conclusion, the failure of neuroprotection by ALS SC is an important mechanism implicated in the MN cell death, with great therapeutic potential

Type 1 diabetes develops through the progressive destruction of the insulin-producing beta-cells. Regeneration or replacement of beta-cells is therefore needed to restore normal glucose homeostasis. Presently, normoglycemia can be achieved by the transplantation of whole pancreas or isolated islets of Langerhans. Islet transplantation can be performed through a simple laparoscopic procedure, but the long-term graft survival is low due to poor revascularization and early cell death. This thesis examined the possibility of using different auxiliary cells (Schwann cells, endothelial progenitor cells, and neural crest stem cells) to improve the engraftment and function of endogenous and transplanted islets. Co-transplantation of Schwann cells with islets improved islet graft function early after transplantation, and caused an increased islet mass at one month posttransplantation. However, the vascular densities of these grafts were decreased, which also related to an impaired graft function. Islet grafts containing endothelial progenitor cells had a superior vascular density, with functional chimeric blood vessels and substantially higher blood perfusion and oxygen tension than control transplants. By culturing and transplanting islets together with neural crest stem cells it was found that islets exposed to these cells had a higher beta-cell proliferation compared with control islets. At one month posttransplantation, the grafts with neural crest stem cells also had a superior vascular- and neural density. The potential of intracardially injected neural crest stem cells to home to the pancreas and ameliorate hyperglycemia in diabetic mice was investigated. During a three-week period after such cell treatment blood glucose concentrations decreased, but were not fully normalized. Neural crest stem cells were present in more than 10% of the pancreatic islets at two days postinjection, at which time the beta-cell proliferation was markedly increased when compared with islets of saline-treated diabetic animals. Three weeks later, a doubled beta-cell mass was observed in animals receiving neural crest stem cells. In summary, islets can easily be transplanted together with different auxiliary cells. Some of these cells provide the possibility of improving vascular- and neural engraftment, as well as beta-cell growth and survival. Systemic administration of neural crest stem cells holds the potential of regenerating the endogenous beta-cells.